For a long time, a luxury beauty or wellness brand looking at Israel had two options, and both of them cost something. The first was to stay out. The market looked small, the regulatory file looked complicated, and the effort was hard to justify against larger territories. The second was to go in through a volume distributor, which usually meant the brand arrived as another line item, priced and placed next to things it had nothing in common with. Dana Zilberstein built Fine Rituals to offer a third option, and the whole business follows from that decision.
Dana Zilberstein is Co-Founder and CEO of Fine Rituals, a boutique importer based in Netanya that brings the world's most exclusive luxury beauty and wellness brands into Israel. She owns partnership strategy and market entry across Israel, Asia, and the Middle East. More than 20 international brands have come into the Israeli market through her work, and that record is the thing she points to when a founder asks whether any of this will hold. She has done it enough times to know what works.
The problem she set out to solve
The regulatory path into Israel is where most brands stop. Ministry of Health registration, toxicological review, customs, and the local supply chain add up to a body of work that a small team cannot absorb and a large team struggles to justify opening a branch for. Faced with that, brands either walked away or handed the problem to someone whose business model depended on moving units.
Dana Zilberstein's answer was to take the entire entry in house. Regulatory and registration, international shipping and customs, warehousing and local supply, and then placement. One roof, one accountable party, one path from the first conversation to the shelf. A brand owner does not assemble a chain of vendors and hope the pieces line up. They work with Fine Rituals, and Fine Rituals owns the outcome.
The second half of the answer is where the brand lands once it clears the border. Fine Rituals places through curated, scarcity led distribution in boutiques, premium clinics, and luxury spas, and deliberately bypasses mass retail. That is not a preference expressed after the fact. It is decided before the file is opened, because placement is the part of an entry that a brand cannot take back.
Two kinds of brand owner, one answer
The brand owners who come to Dana Zilberstein tend to arrive from two very different places, and she has an answer for both.
The founder whose brand is her life's work
One is the creator of a small clean luxury line. She built the formula, the packaging, the voice, and the standard. Her fear is not that the brand will fail abroad. Her fear is that it will succeed in a shape she does not recognise, placed by people who do not read her aesthetic, while her cash flow is stretched thin funding a launch she cannot supervise from another country. What she wants is validation in a new market without giving up what makes the brand hers.
For that founder, the promise is specific. The regulatory maze is handled by people who own the science rather than outsourcing the forms. The placement is chosen one account at a time. Nothing goes anywhere that would cheapen the brand, and volume is never the measure of whether the entry worked.
The export lead with a board to answer for
The other is a VP of export at a larger company, running on data and reporting to a CFO who wants every dollar explained. Israel on its own rarely justifies a branch office, and managing a separate set of vendors for every region creates work that never ends. What that executive needs is a launch that is clean, on budget, and defensible in a board meeting.
For that person, the one roof structure is the argument. There is a single counterpart covering regulatory, logistics, and placement, with a track record of more than 20 brands behind it. The entry is planned, the positioning is agreed in advance, and nobody has to explain later why the brand appeared somewhere it should not have.
What sits under the roof
- Regulatory and registration. Israeli Ministry of Health approval and toxicological review handled in house.
- End to end logistics. International shipping, customs, warehousing, and the local supply chain.
- Premium positioning. Curated, scarcity led placement in boutiques, premium clinics, and luxury spas, with mass retail deliberately left out.
Three things that are hard to copy
Dana Zilberstein names three advantages, and all three are choices rather than assets. The first is brand preservation over volume dilution, which is a rule applied even when a larger order is available. The second is in house regulatory and toxicological mastery, which means the science belongs to the company and is not subcontracted to a third party who will not answer the phone when a question comes back. The third is cultural and aesthetic alignment, the judgement about where a brand belongs in a specific market. Taste is the one part of this that cannot be written into a corporate handbook, and it is the part brand founders test first.
Israel first, then the region
The direction Dana Zilberstein has set is to become the gateway for the world's most exclusive beauty and wellness brands into the region. Israel first, then Asia and the Middle East, with the same entry method and the same refusal to trade prestige for reach. Her Co-Founder, Ofri Shaysh, builds the market access side of that work, opening routes for premium brands across the same territories.
What holds it together is a single line she does not soften. Protect the brand first, chase volume never. It is an unusual thing for an importer to say out loud, because it means turning down business that would look fine on a spreadsheet. For a brand owner who has spent years building something worth protecting, it is the only sentence that matters.
Read more about Dana Zilberstein or learn about the company at www.fine-rituals.com.
קרא עוד
Fine Rituals explains why Israeli Ministry of Health registration and toxicological review are kept in house, led by CEO Dana Zilberstein.
Fine Rituals explains why Israeli Ministry of Health registration and toxicological review are kept in house, led by CEO Dana Zilberstein.